Board & Leadership Staff

Board of Directors


Joseph F. Franlin
Neustar, Inc.


Wendi Picker
President and CEO
Accommodations Unlimited


Judith P. Barnhard, CPA
May & Barnhard, PC

Michael Burke, CPA
Yorke, Burke & Lee


Mark Baran
Managing Director
Four Springs Capital, LLC
New Jersey

Padmakumar Kaimal, Ph.D.
Technology Alliance & Business Development
Suven Life Sciences
New Jersey


Edward S. West
Law Offices of Edward S. West

Board of Advisors

Abraham Amoros
Chief of Communications
Office of the Governor of Pennsylvania

Marianne Bouldin
Hope Fund for Sarcoma Research

Nancy Flood Cole
Special Event Consultant

Allan Ettinger
Senior Vice President – Wealth Management
Senior Investment Management Consultant
MorganStanley SmithBarney

Judith A. Franlin
Philanthropist and Community Activist

Sarah Funt
Long & Foster Realtors

Ken Hansen
Sr. Director
Registry Services, Business Development
NeuStar, Inc.

Richard Mallery, Esq.
Managing Partner
Snell & Wilner, LLC

Mary Ann Miller
NFCR Supporter

Stephen Minar
Vice President

William Potter
Robert R. Meredith, Inc.

Zhiqiang Qu
Chief Executive Officer
Beijing Guoxin Spreader S&T Ltd.

Tina Reinprecht

Anne Rouse
NFCR Volunteer

Melissa Siegel
Philanthropist and Community Activist

David M. Sotsky
Financial Advisor
Merrill Lynch

John Stanovick
Mathematical Statistician
United States Department of Agriculture – Forest Service

Brian Vogel
Client Advisor
WMS Partners, LLC

Robin Wang
Musician and Philanthropist

Charles Weatherspoon
Chief Executive Officer
The Corporate CFO

Leadership Team

Franklin C. Salisbury, Jr. Chief Executive Officer

Franklin C. Salisbury, Jr., M.Div., J.D. has served as the Chief Executive Officer of the National Foundation for Cancer Research (NFCR) since 1997, leading NFCR to expand its cancer research program from basic cancer research to translational and clinical research so that the cancer research discoveries made at the bench might reach patients at their bedsides faster. Under his leadership, the 40-year old NFCR has become one of America’s largest public charities dedicated to cancer research.

Franklin came to lead the NFCR after a diverse background in economics, law and religion. Trained as an environmental/public utilities economist, he served as Chairman of Washington, DC’s Consumer Utility Board in the 1980s.

Franklin holds a B.A. in economics from Yale in 1978, a Masters of Arts degree from the University of Chicago, and an M.Div. from Yale Divinity School. He also earned his J.D. from the University of Georgia in 1992.

Sujuan Ba, Ph.D. President and Chief Operating Officer

Dr. Ba is recognized as one of the “Top 300 Women Leaders in Global Health” by the Global Health Programme at the Graduate Institute of International and Development Studies.

Under her leadership, NFCR has established a powerful network of research centers/laboratories in the US and around the world. One of the high-profile and significant research programs emerging from this collaborative approach was the ScreenSaver-LifeSaver Project. Dr. Ba established a partnership between NFCR, United Devices, Inc., Intel Corp., and Oxford University to launch a distributed computing technology-based application linking together more than 3 million PC users globally to create the world’s largest supercomputer which sped up the drug screening process. This program enabled scientists to perform virtual screenings of 3.5 billion small molecules against 12 target proteins to identify new anti-cancer drug candidates.

Dr. Ba has led the Tissue Bank Consortium in Asia to promote the best practices for biorepositories and biobanks. This project is proclaimed an exemplary international platform for private, public and government partnership for international collaboration to advance cancer research.

Dr. Ba led the launch of Szent-Györgyi Prize for Progress in Cancer Research, now an internationally recognized prize for outstanding scientific achievement. Dr. Ba serves on the executive committee of the GBM-AGILE Trial, an initiative to improve the survival of GBM patients with a global force of over 150 neurosurgeons, neuro-oncologists, pathologists, imagers, basic and clinical neuro scientists. This is a model that aims to breakdown silos and build knowledge bases to ensure that precision medicine is available to patients worldwide.

She also serves on the Organizing Committee for the 2015 Personalized Medicine Conference, on the International Consulting Committee of the China National Research Center for Translational Medicine, and on the Scientific Advisory Board of Medelis, Inc.

Learn more about Dr. Sujuan Ba here.

Kwok Leung, Ph.D. Chief Financial Officer and Secretary

Dr. Kwok Leung joined the National Foundation for Cancer Research (NFCR) as a consultant in 2003 and was promoted to Controller in 2008.  He oversees three supporting functions of NFCR’s operations: accounting and reporting, compliance, and human resource and office administration.

Prior to joining NFCR, Dr. Leung was a faculty at the Catholic University of America, and at the University of Maryland, College Park, teaching accounting at both undergraduate and graduate levels.  His research interests were management accounting and executive compensation.  He also served as consulting staff and researcher for the World Bank and U.S. Department of Transportation.

Dr. Leung received his B.B.A (Hon.) from the Chinese University of Hong Kong and his Ph.D. from the University of Maryland, College Park, majoring in accounting and minoring in finance and statistics.  He was a licensed CPA in Maryland.

Michael Wang, Ph.D., MBA, Chief Strategy Officer for Alliances and Partnerships

Dr. Wang is actively involved in developing strategic alliances and critical collaborations with international organizations in both academic and industrial communities and working closely with the Office of Technology Transfer at various universities to facilitate the protection and commercialization of NFCR-sponsored intellectual property (IP) through patent filling and licensing. Dr. Wang has extensive experience in scientific program management, strong capability for technical and financial due diligence, and broad knowledge about early-stage technology evaluation and development., Dr. Wang has previously served as Chief Science Officer overseeing all the aspects of NFCR’s cancer research programs and research initiatives, which is operated at 9 discovery centers and 30 plus laboratories in universities, research institutes, and teaching hospitals in the US, Germany, and China.

Dr. Wang also serves as the Chief Operating Officer for the Asian Fund for Cancer Research (Hong Kong, China). He is actively involved in identifying collaborative opportunities so that cancer researchers from Asia can work closely with scientists from the U.S. and Europe to maximize the utilization of resources.

Dr. Wang received his medical degree from the Second Military Medical College in Shanghai, China, his Ph.D. in molecular biology from Kyoto University, Japan, and his MBA from Penn State University. Before joining NFCR in 2002, Dr. Wang had worked at the University of Pennsylvania as a Research Fellow, and at a leading technology transfer company British Technology Group (BTG) as a Senior Business Development Manager for both the Oncology group and the Genomics & Proteomics group.

Joseph Gillmer, CFRE®, CSPG™, CAP®

Vice President of Development
Certified Fund Raising Executive
Certified Specialist in Planned Giving
Chartered Advisor in Philanthropy

Joe serves as the Vice President of Development with a primary focus on strengthening and diversifying contributed revenue that will allow for NFCR to invest even more in cutting-edge cancer research. Prior to joining NFCR, Joe served as a Client Partner for the American Cancer Society through Merkle Inc. Nonprofit Group, a data-driven, technology-enabled performance marketing agency and as a Corporate Vice President with Community Counselling Service Co., LLC (CCS), an international fundraising and strategic consulting firm. Joe is passionate about philanthropy and firmly believes “that service to humanity is the best work of life” (C. William Brownfield, 1951). With this passion, Joe has assisted nonprofit organizations raise more than $750 million for a variety of philanthropic initiatives since 2001.

Joe has developed and presented on a range of philanthropy topics for the Association of Fundraising Professionals, the Bank of America Nonprofit Impact Series, DC Bar Pro-Bono Program, the Booz Allen Hamilton Nonprofit Speaker Series and the Center for Non-Profit Success as well as for several regional and national conferences. Joe is a member of the Association of Fundraising Professionals (including the Washington DC Chapter), the Partnership for Philanthropic Planning, the National Capital Gift Planning Council and the Direct Marketing Association of Washington.

Joe graduated with two Bachelor of Arts degrees from Indiana University of Pennsylvania (Journalism and Political Science). He has earned the Certified Fund Raising Executive (CFRE®) professional designation from CFRE International (2007), the Certified Specialist in Planned Giving (CSPG™) designation from the American Institute for Philanthropic Studies (2008) and the Chartered Advisor in Philanthropy (CAP®) designation from The American College (2015). In addition, Joe holds a certificate in Nonprofit Executive Leadership from The Lilly Family School of Philanthropy at Indiana University (2012).



Melissa White Donor Relations Officer
Elaine Currie Donor Relations Officer


Join Our Team

The National Foundation for Cancer Research seeks unpaid interns and candidates for full-time positions.

If you are a highly-motivated and detail-oriented individual interested in joining an organization that believes in Research for a Cure, please email your resume and cover letter to